Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021

Upgrades

Canaccord Genuity upgraded the previous rating for Precision Drilling Corp PDS from Hold to Buy. For the second quarter, Precision Drilling had an EPS of $4.65, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $44.52 and a 52-week-low of $11.62. At the end of the last trading period, Precision Drilling closed at $30.48.
Susquehanna upgraded the previous rating for DXC Technology Co DXC from Neutral to Positive. In the first quarter, DXC Technology showed an EPS of $0.84, compared to $0.21 from the year-ago quarter. The current stock performance of DXC Technology shows a 52-week-high of $44.18 and a 52-week-low of $15.64. Moreover, at the end of the last trading period, the closing price was at $36.07.
According to Wells Fargo, the prior rating for Sunstone Hotel Investors Inc SHO was changed from Underweight to Equal-Weight. Sunstone Hotel Invts earned $0.01 in the second quarter, compared to $0.31 in the year-ago quarter. The current stock performance of Sunstone Hotel Invts shows a 52-week-high of $13.74 and a 52-week-low of $7.12. Moreover, at the end of the last trading period, the closing price was at $10.95.
According to Goldman Sachs, the prior rating for AGCO Corp AGCO was changed from Neutral to Buy. In the second quarter, AGCO showed an EPS of $2.88, compared to $1.11 from the year-ago quarter. The stock has a 52-week-high of $158.62 and a 52-week-low of $69.68. At the end of the last trading period, AGCO closed at $131.93.
For Ovintiv Inc OVV, Cowen & Co. upgraded the previous rating of Market Perform to Outperform. In the second quarter, Ovintiv showed an EPS of $1.11, compared to $0.43 from the year-ago quarter. At the moment, the stock has a 52-week-high of $33.46 and a 52-week-low of $6.81. Ovintiv closed at $24.47 at the end of the last trading period.

See all analyst ratings upgrades.

Downgrades

For Victoria's Secret & Co VSCO, Morgan Stanley downgraded the previous rating of Overweight to Equal-Weight. Interestingly, in the second quarter, Victoria's Secret's EPS was $1.71. At the end of the last trading period, Victoria's Secret closed at $66.09.
Craig-Hallum downgraded the previous rating for Trillium Therapeutics Inc TRIL from Buy to Hold. Trillium Therapeutics earned $0.18 in the second quarter, compared to $0.28 in the year-ago quarter. The current stock performance of Trillium Therapeutics shows a 52-week-high of $20.96 and a 52-week-low of $5.80. Moreover, at the end of the last trading period, the closing price was at $17.59.
For Genmab A/S GMAB, HC Wainwright & Co. downgraded the previous rating of Buy to Neutral. In the second quarter, Genmab showed an EPS of $0.75, compared to $7.58 from the year-ago quarter. The current stock performance of Genmab shows a 52-week-high of $48.85 and a 52-week-low of $30.10. Moreover, at the end of the last trading period, the closing price was at $48.58.
Truist Securities downgraded the previous rating for Broadstone Net Lease Inc BNL from Buy to Hold. Broadstone Net Lease earned $0.32 in the second quarter. At the moment, the stock has a 52-week-high of $27.32 and a 52-week-low of $15.90. Broadstone Net Lease closed at $26.56 at the end of the last trading period.
For Theravance Biopharma Inc TBPH, Cowen & Co. downgraded the previous rating of Outperform to Market Perform. For the second quarter, Theravance Biopharma had an EPS of $0.80, compared to year-ago quarter EPS of $1.00. The stock has a 52-week-high of $22.74 and a 52-week-low of $12.62. At the end of the last trading period, Theravance Biopharma closed at $14.17.
For Cummins Inc CMI, Goldman Sachs downgraded the previous rating of Buy to Neutral. For the second quarter, Cummins had an EPS of $4.10, compared to year-ago quarter EPS of $1.95. The stock has a 52-week-high of $277.09 and a 52-week-low of $199.70. At the end of the last trading period, Cummins closed at $235.25.
According to JMP Securities, the prior rating for Trillium Therapeutics Inc TRIL was changed from Market Outperform to Market Perform. In the second quarter, Trillium Therapeutics showed an EPS of $0.18, compared to $0.28 from the year-ago quarter. The current stock performance of Trillium Therapeutics shows a 52-week-high of $20.96 and a 52-week-low of $5.80. Moreover, at the end of the last trading period, the closing price was at $17.59.
Raymond James downgraded the previous rating for Landmark Infrastructure Partners LP LMRK from Outperform to Market Perform. Landmark Infrastructure earned $0.38 in the second quarter, compared to $0.33 in the year-ago quarter. The current stock performance of Landmark Infrastructure shows a 52-week-high of $16.30 and a 52-week-low of $8.91. Moreover, at the end of the last trading period, the closing price was at $16.16.

See all analyst ratings downgrades.

Initiations

Roth Capital initiated coverage on Aviat Networks Inc AVNW with a Buy rating. The price target for Aviat Networks is set to $49.00. For the third quarter, Aviat Networks had an EPS of $0.49, compared to year-ago quarter EPS of $0.39. The current stock performance of Aviat Networks shows a 52-week-high of $87.13 and a 52-week-low of $18.50. Moreover, at the end of the last trading period, the closing price was at $37.75.
Mizuho initiated coverage on IN8bio Inc INAB with a Buy rating. The price target for IN8bio is set to $12.00.IN8bio closed at $8.09 at the end of the last trading period.
With an Outperform rating, Wedbush initiated coverage on Omega Therapeutics Inc OMGA. The price target seems to have been set at $36.00 for Omega Therapeutics. Moreover, at the end of the last trading period, the closing price was at $22.39.
Stephens & Co. initiated coverage on MaxCyte Inc MXCT with an Overweight rating. The price target for MaxCyte is set to $19.00. At the end of the last trading period, MaxCyte closed at $14.34.
Oppenheimer initiated coverage on Shift Technologies Inc SFT with an Outperform rating. The price target for Shift Technologies is set to $12.00. Shift Technologies earned $0.41 in the second quarter, compared to $5.79 in the year-ago quarter. The stock has a 52-week-high of $12.34 and a 52-week-low of $6.17. At the end of the last trading period, Shift Technologies closed at $7.34.
Stephens & Co. initiated coverage on Dole PLC DOLE with an Overweight rating. The price target for Dole is set to $19.00. For the second quarter, Dole had an EPS of $0.28, compared to year-ago quarter EPS of $0.80. At the end of the last trading period, Dole closed at $16.05.
With an Overweight rating, JP Morgan initiated coverage on RxSight Inc RXST. The price target seems to have been set at $16.00 for RxSight. Moreover, at the end of the last trading period, the closing price was at $12.00.
B of A Securities initiated coverage on Rani Therapeutics Holdings Inc RANI with a Buy rating. The price target for Rani Therapeutics Hldgs is set to $23.00. At the end of the last trading period, Rani Therapeutics Hldgs closed at $17.13.
With a Buy rating, Stifel initiated coverage on WM Technology Inc MAPS. The price target seems to have been set at $19.00 for WM Technology. WM Technology earned $0.17 in the second quarter. The stock has a 52-week-high of $22.24 and a 52-week-low of $11.87. At the end of the last trading period, WM Technology closed at $13.31.
Seaport Global initiated coverage on Worthington Industries Inc WOR with a Neutral rating. In the fourth quarter, Worthington Industries showed an EPS of $2.33, compared to $0.49 from the year-ago quarter. At the moment, the stock has a 52-week-high of $75.45 and a 52-week-low of $35.69. Worthington Industries closed at $58.61 at the end of the last trading period.
Seaport Global initiated coverage on Steel Dynamics Inc STLD with a Buy rating. The price target for Steel Dynamics is set to $75.00. Steel Dynamics earned $3.40 in the second quarter, compared to $0.47 in the year-ago quarter. The stock has a 52-week-high of $74.37 and a 52-week-low of $28.31. At the end of the last trading period, Steel Dynamics closed at $68.96.
Seaport Global initiated coverage on Reliance Steel & Aluminum Co RS with a Buy rating. The price target for Reliance Steel & Aluminum is set to $165.00. Reliance Steel & Aluminum earned $5.06 in the second quarter, compared to $1.36 in the year-ago quarter. The current stock performance of Reliance Steel & Aluminum shows a 52-week-high of $181.21 and a 52-week-low of $99.98. Moreover, at the end of the last trading period, the closing price was at $151.08.